Literature DB >> 9070484

Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases.

A P Burke1, R M Thomas, A M Elsayed, L H Sobin.   

Abstract

BACKGROUND: Carcinoid tumors of the gastrointestinal tract differ in their clinical and histopathologic features, depending on the site of origin. There are few clinicopathologic studies that specifically describe jejunoileal carcinoid tumors.
METHODS: One hundred sixty-seven ileal and jejunal carcinoids were retrospectively studied with emphasis on clinical, pathologic, immunohistochemical, and prognostic features.
RESULTS: The mean age of patients at the time of presentation was 62 +/- 12 years (range, 13-93 years). Eight patients had carcinoid syndrome (5%) and 1 had Zollinger-Ellison syndrome. Twenty-six percent of tumors were multiple, and 77% were transmurally invasive; 31% had regional lymph node metastases only, and 32% had liver or mesenteric metastases. Ninety-three percent of tumors had an insular growth pattern. Serotonin was expressed in 86% of tumors (86 of 102), chromogranin in 92%, and neuron specific enolase in 95%. Twenty percent of tumors (10 of 51) expressed prostatic acid phosphatase; 96% were argyrophil, and 98% argentaffin. Of 80 cases with follow-up data (mean follow-up, 52 +/- 5 months), 21% were dead of disease, 16% were dead of other causes, 19% were alive with disease, and 44% had no evidence of disease at last follow-up. The 5-year Kaplan-Meier survival estimate for all cases was 58%. By univariate analysis, survival was negatively correlated with distant metastases at the time of surgery (P = 0.002), mitotic rate (P = 0.01), tumor multiplicity (P = 0.01), the presence of carcinoid syndrome (P = 0.02), depth of invasion (P = 0.03), and female gender (P = 0.05); by multivariate analysis, survival was negatively associated with distant metastasis (P = 0.002), carcinoid syndrome (P = 0.01), and female gender (P = 0.03).
CONCLUSIONS: Jejunoileal carcinoid tumors have a relatively high rate of transmural invasion and aggressive clinical behavior. They are usually insular and largely argentaffin, with a high rate of chromogranin and serotonin positivity. These features differentiate jejunoileal carcinoids from other gastrointestinal carcinoids.

Entities:  

Mesh:

Year:  1997        PMID: 9070484

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  50 in total

Review 1.  The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.

Authors:  Simon Schimmack; Bernhard Svejda; Benjamin Lawrence; Mark Kidd; Irvin M Modlin
Journal:  Langenbecks Arch Surg       Date:  2011-01-28       Impact factor: 3.445

2.  An unusual presentation of neuroendocrine tumor of the small bowel.

Authors:  Michele Tedeschi; Giuseppe Piccinni; Germana Lissidini; Angela Gurrado; Domenico Piscitelli; Ilaria Fabiola Franco; Alessandro De Luca; Mario Testini
Journal:  Updates Surg       Date:  2012-06-08

3.  Significance of cytodiagnosis in primary carcinoid tumor of the middle ear: A case report.

Authors:  Kiminobu Sato; Ryota Mihashi; Takashi Kurita; Hirohito Umeno; Tomoko Yoshida; Akihiko Kawahara; Jun Akiba; Hirohisa Yano
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

Review 4.  [Classification of gastro-entero-pancreatic neuroendocrine tumors].

Authors:  A Perren; A Schmitt; P Komminoth; M Pavel
Journal:  Radiologe       Date:  2009-03       Impact factor: 0.635

Review 5.  Flushing Disorders Associated with Gastrointestinal Symptoms: Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila.

Authors:  Vaibhav Rastogi; Devina Singh; Joseph J Mazza; Dipendra Parajuli; Steven H Yale
Journal:  Clin Med Res       Date:  2018-04-12

Review 6.  Small bowel neuroendocrine tumors: From pathophysiology to clinical approach.

Authors:  Sofia Xavier; Bruno Rosa; José Cotter
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

7.  Grade 3 Neuroendocrine Tumor (G3 NET) in a Background of Multiple Serotonin Cell Neoplasms of the Ileum Associated with Carcinoid Syndrome and Aggressive Behavior.

Authors:  Francesca Capuano; Oneda Grami; Luigi Pugliese; Marco Paulli; Andrea Pietrabissa; Enrico Solcia; Alessandro Vanoli
Journal:  Endocr Pathol       Date:  2018-12       Impact factor: 3.943

Review 8.  Advances in the treatment of neuroendocrine tumors.

Authors:  Matthew Kulke
Journal:  Curr Treat Options Oncol       Date:  2005-09

9.  Is Multifocality an Indicator of Aggressive Behavior in Small Bowel Neuroendocrine Tumors?

Authors:  Allen B Choi; Jessica E Maxwell; Kendall J Keck; Andrew J Bellizzi; Joseph S Dillon; Thomas M OʼDorisio; James R Howe
Journal:  Pancreas       Date:  2017-10       Impact factor: 3.327

10.  Chronic subacute bowel obstruction caused by carcinoid tumour misdiagnosed as irritable bowel syndrome: a case report.

Authors:  Henrietta M Wilson
Journal:  Cases J       Date:  2009-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.